Media
Displaying 41 - 50 of 57
Geneva, Switzerland – Maiken Engsbye has been appointed as Vice President, Human Resources (HR) for Santen EMEA and will be a key member of the senior management team. Maiken will be responsible for…
Geneva, Switzerland – Santen EMEA is proud to support World Sight Day (WSD) 2019, an annual initiative hosted by the International Association for the Prevention of Blindness (IAPB). WSD is an…
CE marked and approved as a monofocal hydrophobic intraocular lens (IOL), the xact™ Mono-EDoF™ is a hydrophobic diffractive IOL with 4 diffractive rings developed by Santen1
Provides excellent…
Geneva, Switzerland – Santen EMEA’s significant expansion into the surgical devices arena is underlined by the company’s activities at this year’s European Society of Cataract and Refractive Surgeons…
Santen is delighted to have the opportunity to make our first appearance and start discussions with customers at the XIV International Congress of the Middle East and Africa Council of Ophthalmology…
Oxford, UK and Osaka, Japan – Oxford Biomedica plc (LSE:OXB) a leading gene and cell therapy group, and Santen Pharmaceutical Co., Ltd., the market leader for prescription ophthalmic pharmaceuticals…
Geneva, Switzerland – Santen EMEA is delighted to share the preliminary results of its two real world evidence (RWE) studies, VISIONARY and PERSPECTIVE at this year’s European Society of…
Santen and the International Glaucoma Association (IGA) have joined forces to create a unique interactive 'eye test' to demonstrate what the world looks like to people living with glaucoma. The…
Today Santen announces that the preservative-free, formulation Cosopt iMulti® (20mg/ml dorzolamide + 5mg/ml timolol eye drops, solution) and the preservative-free multi-dose formulation of Taflotan®/…
Santen EMEA is proud to have supported the 13th European Glaucoma Society’s two-day Residents’ Course held on 8-9 February 2019 in Mainz, Germany. Over 160 ophthalmology residents from across Europe…
